I
105TH CONGRESS
1ST SESSION
H. R. 2610
To amend the National Narcotics Leadership Act of 1988 to extend the
authorization for the Office of National Drug Control Policy until Sep-
tember 30, 1999, to expand the responsibilities and powers of the Direc-
tor of the Office of National Drug Control Policy, and for other purposes.
IN THE HOUSE OF REPRESENTATIVES
OCTOBER 6, 1997
Mr. HASTERT introduced the following bill; which was referred to the
Committee on Government Reform and Oversight
A BILL
To amend the National Narcotics Leadership Act of 1988
to extend the authorization for the Office of National
Drug Control Policy until September 30, 1999, to expand
the responsibilities and powers of the Director of the
Office of National Drug Control Policy, and for other
purposes.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE; AMENDMENT REFERENCES.
(a) SHORT TITLE.—This Act may be cited as the
‘‘National Narcotics Leadership Act Amendments of
1997’’.
(b) AMENDMENT REFERENCES.—Except as other-
wise expressly provided, whenever in this Act an amend-
ment or repeal is expressed in terms of an amendment
to, or repeal of, a section or other provision, the reference
shall be considered to be made to a section or other provi-
sion of the National Narcotics Leadership Act of 1988 (21
U.S.C. 1501 et seq.).
SEC. 2. DEPUTY DIRECTOR FOR STATE AND LOCAL AF-
FAIRS AND DEPUTY DIRECTOR OF INTEL-
LIGENCE.
(a) ESTABLISHMENT.—Section 1002 (21 U.S.C.
1501) is amended—
(1) in subsection (b)—
(A) by amending paragraph (2) to read as
follows:
‘‘(2) There shall be in the Office of National Drug
Control Policy a Deputy Director for Demand Reduction,
a Deputy Director for Supply Reduction, a Deputy Direc-
tor for State and Local Affairs, and a Deputy Director
of Intelligence.’’; and
(B) by amending paragraph (3) to read as
follows:
‘‘(3) The Deputy Director for Demand Reduction, the
Deputy Director for Supply Reduction, the Deputy Direc-
tor for State and Local Affairs, and the Deputy Director
of Intelligence shall assist the Director in carrying out the
responsibilities of the Director under this Act.’’; and
(2) by amending subsection (c)(2) to read as
follows:
‘‘(2) The Deputy Director for State and Local Affairs
shall be the head of the Bureau of State and Local Af-
fairs.’’.
(b) APPOINTMENT.—
(1) IN GENERAL.—Section 1003(a) (21 U.S.C.
1502(a)) is amended—
(A) in each of paragraphs (1) and (2), by
striking ‘‘and the Associate Director for Na-
tional Drug Control Policy’’ and inserting ‘‘,
the Deputy Director for State and Local Af-
fairs, and the Deputy Director of Intelligence’’;
and
(B) in paragraph (2), by striking ‘‘, a Dep-
uty Director, or Associate Director’’ and insert-
ing ‘‘or as a Deputy Director’’.
(2) DEADLINE FOR NOMINATION.—The Presi-
dent shall submit to the Senate nominations of indi-
viduals for appointment as the Deputy Director for
Demand Reduction, the Deputy Director for Supply
Reduction, the Deputy Director for State and Local
Affairs and the Deputy Director of Intelligence of
the Office of National Drug Control Policy by not
later than 90 days after the date of the enactment
of this Act.
(3) CONTINUED SERVICE OF ASSOCIATE DIREC-
TOR.—The individual serving on the date of the en-
actment of this Act as Associate Director for Na-
tional Drug Control Policy may act as the Deputy
Director for State and Local Affairs until such time
as an individual is appointed to that position in ac-
cordance with the amendments made by this Act.
(4) CLERICAL
AMENDMENT.—The heading of
section 1003 (21 U.S.C. 1502) amended to read as
follows:
‘‘SEC. 1003. APPOINTMENT AND DUTIES OF DIRECTOR AND
DEPUTY DIRECTORS.’’.
(c) COMPENSATION.—
(1) IN GENERAL.—Chapter 53 of title 5, United
States Code, is amended—
(A) in section 5314, by inserting after the
item relating to the Deputy Director for Supply
Reduction, Office of National Drug Control
Policy, the following:
‘‘Deputy Director for State and Local Affairs,
Office of National Drug Control Policy.
‘‘Deputy Director of Intelligence, Office of Na-
tional Drug Control Policy.’’; and
(B) in section 5315, by striking the item
relating to the Associate Director for National
Drug Control Policy, Office of National Drug
Control Policy.
(2) CLERICAL AMENDMENT.—Section 1003 (21
U.S.C. 1502) is amended by striking paragraph
(4)(C).
SEC. 3. EXPANSION OF RESPONSIBILITIES OF DIRECTOR.
(a) EXPANSION
OF
RESPONSIBILITIES.—Section
1003(b) (21 U.S.C. 1502(b)) is amended—
(1) by amending paragraph (1) to read as fol-
lows:
‘‘(1) establish Federal policies, objectives, goals,
priorities, and performance measures (including spe-
cific annual agency targets expressed in terms of
precise percentages) for the National Drug Control
Program and for each National Drug Control Pro-
gram agency, which include targets for the following:
‘‘(A) reduction of unlawful drug use to 2
percent of the population of the United States
or less by December 31, 2001 (as measured in
terms of overall illicit drug use during the past
30 days by the National Household Survey),
and achievement of at least 25 percent of such
reduction during each of 1998, 1999, 2000, and
2001;
‘‘(B) reduction of adolescent unlawful drug
use (as measured in terms of illicit drug use
during the past 30 days by the Monitoring the
Future Study of the University of Michigan or
the National PRIDE Survey conducted by the
National Parents’ Resource Institute for Drug
Education) to 2 percent of the population of the
United States or less by December 31, 2001,
and achievement of at least 25 percent of such
reduction during each of 1998, 1999, 2000, and
2001;
‘‘(C) reduction of the availability of co-
caine, heroin, marijuana, and methamphet-
amine in the United States by 80 percent by
December 31, 2001;
‘‘(D) reduction of the respective nationwide
average street purity levels for cocaine, heroin,
marijuana, and methamphetamine (as esti-
mated by the interagency drug flows assessment
led by the Office of National Drug Control Pol-
icy, and based on statistics collected by the
Drug Enforcement Administration and other
National Drug Control Program agencies iden-
tified as relevant by the Director) by 60 percent
by December 31, 2001, and achievement of at
least 25 percent of each such reduction during
each of 1998, 1999, 2000, and 2001;
‘‘(E) reduction of drug-related crime in the
United States by 50 percent by December 31,
2001, and achievement of at least 25 percent of
such reduction during each of 1998, 1999,
2000, and 2001, including—
‘‘(i) reduction of State and Federal
unlawful drug trafficking and distribution;
‘‘(ii) reduction of State and Federal
crimes committed by persons under the in-
fluence of unlawful drugs; and
‘‘(iii) reduction of State and Federal
crimes committed for the purpose of ob-
taining unlawful drugs or obtaining prop-
erty that is intended to be used for the
purchase of unlawful drugs; and
‘‘(F) reduction of drug-related emergency
room incidents in the United States (as meas-
ured by data of the Drug Abuse Warning Net-
work on illicit drug abuse), including incidents
involving gunshot wounds and automobile acci-
‘‘(A) success in reducing domestic and for-
eign sources of illegal drugs;
‘‘(B) success in protecting the borders of
the United States (and in particular the South-
west border of the United States) from penetra-
tion by illegal narcotics;
‘‘(C) success in reducing violent crime as-
sociated with drug use in the United States;
‘‘(D) success in reducing the negative
health and social consequences of drug use in
the United States; and
‘‘(E) implementation of drug treatment
and prevention programs in the United States
and improvements in the adequacy and effec-
tiveness of such programs;
‘‘(10) submit to Congress on a semi-annual
basis, not later than 60 days after the date of the
last day of the applicable 6-month period, a sum-
mary of—
‘‘(A) each of the evaluations received by
the Director under paragraph (9); and
‘‘(B) the progress of each National Drug
Control Program agency toward the drug con-
trol program goals of the agency using the per-
formance measures described in paragraph (1);
‘‘(14) act as a representative of the President
before Congress on all aspects of the National Drug
Control Program;
‘‘(15) act as the primary spokesperson of the
President on drug issues;
‘‘(16) make recommendations to National Drug
Control Program agency heads with respect to im-
plementation of Federal counter-drug programs; and
‘‘(17) take such actions as necessary to oppose
any attempt to legalize the use of a substance (in
any form) that—
‘‘(A) is listed in schedule I of section 112
of the Controlled Substances Act (21 U.S.C.
812); and
‘‘(B) has not been approved for use for
medical purposes by the Food and Drug Ad-
ministration.’’.
(b) SURVEY OF DRUG USE.—(1) The University of
Michigan shall not be prohibited under any law from con-
ducting the survey of drug use among young people in the
United States known as the Monitoring the Future Sur-
vey.
(2) The National Parents’ Resource Institute for
Drug Education in Atlanta, Georgia, shall not be prohib-
ited under any law from conducting the survey of drug
use among young people in the United States known as
the National PRIDE Survey.
SEC. 4. EXPANSION OF POWERS OF DIRECTOR.
Section 1003(d) (21 U.S.C. 1502(d)) is amended—
(1) in paragraph (9), by striking the period and
inserting a semicolon; and
(2) by adding at the end the following new
paragraphs:
‘‘(10) require the heads of National Drug Con-
trol Program agencies to provide the Director with
statistics, studies, reports, and any other informa-
tion regarding Federal control of drug abuse;
‘‘(11) require the heads of National Drug Con-
trol Program agencies to provide the Director with
information regarding any position (before an indi-
vidual is nominated for such position) that—
‘‘(A) relates to the National Drug Control
Program;
‘‘(B) is at or above the level of Deputy As-
sistant Secretary; and
‘‘(C) involves responsibility for Federal
counternarcotics or anti-drug programs; and
‘‘(12) make recommendations to the National
Drug Intelligence Center on the specific projects
that the Director determines will enhance the effec-
tiveness of implementation of the National Drug
Control Strategy.’’.
SEC. 5. SUBMISSION OF NATIONAL DRUG CONTROL STRAT-
EGY.
(a) IN GENERAL.—Section 1005(a) is amended—
(1) by amending paragraph (2)(A) to read as
follows:
‘‘(A) include comprehensive, research-based,
specific, long-range goals and performance measures
(including specific annual targets expressed in terms
of precise percentages) for reducing drug abuse and
the consequences of drug abuse in the United
States;’’;
(2) by striking ‘‘and’’ at the end of paragraph
(2)(C);
(3) by striking paragraph (2)(D);
(4) by adding at the end of paragraph (2) the
following new paragraphs:
‘‘(D) include 4-year projections for National
Drug Control Program priorities (including budget
priorities); and
‘‘(E) review international, Federal, State, local,
and private sector drug control activities to ensure
that the United States pursues well-coordinated and
effective drug control at all levels of government.’’;
(5) in paragraph (3)(A), by striking clauses (iv)
and (v) and inserting the following:
‘‘(iv) private citizens and organizations
with experience and expertise in demand reduc-
tion;
‘‘(v) private citizens and organizations with
experience and expertise in supply reduction;
and
‘‘(vi) appropriate representatives of foreign
governments.’’;
(6) in paragraph (4)—
(A) in subparagraph (B), by amending
clauses (i) through (vi) to read as follows:
‘‘(i) the quantities of cocaine, heroin, mari-
juana, methamphetamine, ecstasy, and rohypnol
available for consumption in the United States;
‘‘(ii) the amount of cocaine, heroin, mari-
juana, ecstasy, rohypnol, methamphetamine,
and precursor chemicals entering the United
States;
‘‘(iii) the number of hectares of marijuana,
poppy, and coca cultivated and destroyed do-
mestically and in other countries;
‘‘(iv) the number of metric tons of mari-
juana, cocaine, heroin, and methamphetamine
seized;
‘‘(v) the number of cocaine and meth-
amphetamine processing labs destroyed domes-
tically and in other countries;
‘‘(vi) changes in the price and purity of
heroin and cocaine, changes in price of meth-
amphetamine, 
and 
changes 
in
tetrahydrocannabinol level of marijuana;’’;
(B) by striking ‘‘and’’ at the end of sub-
paragraph (C);
(C) by striking the period at the end of
subparagraph (D) and inserting ‘‘; and’’; and
(D) by adding at the end the following new
subparagraph:
‘‘(E) an assessment of the cultivation of illegal
drugs in the United States.’’; and
(7) in paragraph (5)—
(A) in the matter preceding subparagraph
(A), by striking ‘‘February 1, 1995’’ and insert-
ing ‘‘February 1, 1998’’;
(B) in the matter preceding subparagraph
(A), by striking ‘‘second’’;
(C) by striking ‘‘and’’ at the end of sub-
paragraph (C);
(D) by striking the period at the end of
subparagraph (D) and inserting ‘‘; and’’; and
(E) by adding at the end the following new
subparagraph:
‘‘(E) a description of the National Drug Con-
trol Program performance measures described in
subsection (a)(2)(A).’’.
(b) GOALS AND PERFORMANCE MEASURES FOR NA-
TIONAL DRUG CONTROL STRATEGY.—Section 1005(b) is
amended—
(1) in the heading, by striking ‘‘, OBJECTIVES,
AND PRIORITIES’’ and inserting ‘‘AND PERFORM-
ANCE MEASURES’’;
(2) in the matter after the heading, by inserting
‘‘(1)’’ before ‘‘Each National Drug Control Strat-
egy’’;
(3) by redesignating paragraphs (1) through
(6) as subparagraphs (A) through (F);
(4) in subparagraph (A) (as redesignated by
paragraph (3)), by striking ‘‘and priorities’’ and in-
serting ‘‘and performance measures’’;
(5) in subparagraph (C) (as redesignated by
paragraph (3)), by striking ‘‘3-year projections’’ and
inserting ‘‘4-year projections’’; and
(6) by adding at the end the following new
paragraph:
‘‘(2) In establishing the performance measures re-
quired by this subsection, the Director shall—
‘‘(A) establish performance measures and tar-
gets expressed in terms of precise percentages for
each National Drug Control Strategy goal and objec-
tive;
‘‘(B) revise such performance measures and
targets as necessary, and reflect such performance
measures and targets in the National Drug Control
Program budget submitted to Congress;
‘‘(C) consult with affected National Drug Con-
trol Program agencies;
‘‘(D) identify programs and activities of Na-
tional Drug Control Program agencies that support
the goals of the National Drug Control Strategy;
‘‘(E) evaluate in detail the implementation by
each National Drug Control Program agency of pro-
gram activities supporting the National Drug Con-
trol Strategy;
‘‘(F) monitor consistency between the drug-re-
lated goals of the National Drug Control Program
agencies and ensure that drug control agency goals
and budgets fully support, and are fully consistent
with, the National Drug Control Strategy;
‘‘(G) coordinate the development and implemen-
tation of national drug control data collection and
reporting systems to support Federal policy formula-
tion and performance measurement;
‘‘(H) ensure that no Federal drug control funds
are expended for any study or contract relating to
the legalization (for a medical use or any other use)
of a substance listed in schedule I of section 112 of
the Controlled Substances Act (21 U.S.C. 812) ex-
cept as authorized by such Act; and
‘‘(I) ensure that no Federal funds appropriated
for the High Intensity Drug Trafficking Program
are expended for the expansion of drug treatment
programs.’’.
SEC. 6. REPORT ON DESIGNATION OF HIGH INTENSITY
DRUG TRAFFICKING AREAS.
Section 1005(c)(3) is amended to read as follows:
‘‘(3) Not later than March 1st of each year, the Di-
rector shall submit to Congress a report—
‘‘(A) on the effectiveness of, and need for, the
designation of areas under this subsection as high
intensity drug trafficking areas; and
‘‘(B) that includes any recommendations of the
Director for legislative action with respect to such
designation.’’.
SEC. 7. REPROGRAMMING AND TRANSFER OF FUNDS.
(a) EXPANSION OF TRANSFER AUTHORITY.—Section
1003(d)(8) (21 U.S.C. 1502(d)(8)) is amended to read as
follows:
‘‘(8) except to the extent that the Director’s au-
thority under this paragraph is limited in an annual
appropriations Act, transfer funds appropriated to a
National Drug Control Program agency account to
a different National Drug Control Program agency
account in an amount that does not exceed 5 percent
of the greater amount appropriated to either ac-
count, upon advance approval of the Committees on
Appropriations, and advance notice of the authoriz-
ing Committees, of each House of Congress.
(b) 
REPORT.—Section 
1003(c)(7) 
(21 
U.S.C.
1502(c)(7)) is amended to read as follows:
‘‘(7)(A) The Director shall report to Congress on a
quarterly basis (beginning with the first quarter of 1998)
on—
‘‘(i) the need for any reprogramming or trans-
fer of funds appropriated for National Drug Control
Program activities; and
‘‘(ii) any funds appropriated for National Drug
Control Program activities that were reprogrammed
or transferred during the quarter covered by the re-
port.
‘‘(B) The Director shall report to Congress as re-
quired by paragraph (A) not later than 30 days after the
last day of each applicable quarter.’’.
SEC. 8. LONG-TERM PLAN FOR REDUCTION OF DRUG USE.
Section 1003 (21 U.S.C. 1502) is amended by adding
at the end the following new subsection:
‘‘(g) LONG-TERM PLAN FOR REDUCTION OF DRUG
USE.—Not later than March 1, 1998, the Director shall
submit to Congress a long-term plan for reducing the pop-
ulation of illegal drug users in the United States by De-
cember 31, 2001, to 2 percent of the population of the
United States or less. Such plan shall include—
‘‘(1) a request for funds and other resources
necessary to achieve such reduction within the guide-
lines of the balanced budget agreement of 1997; and
‘‘(2) the justifications for each such request.’’.
SEC. 9. DRUG POLICY COUNCIL.
The National Narcotics Leadership Act of 1988 (21
U.S.C. 1501 et seq.) is further amended by adding at the
end of chapter 1 the following new section:
‘‘SEC. 1012. DRUG POLICY COUNCIL.
‘‘(a) ESTABLISHMENT.—There is established in the
Executive Office of the President a Drug Policy Council,
which shall be composed of the members of the President’s
cabinet, and the purpose of which shall be to make cabi-
net-level decisions regarding national drug policy.
‘‘(b) CHAIRMAN.—The President shall be the Chair-
man of the Drug Policy Council established by subsection
(a).
‘‘(c) EXECUTIVE DIRECTOR.—The Director of the
Office of National Drug Control Policy shall be the Execu-
tive Director of the Drug Policy Council established by
subsection (a).’’.
SEC. 10. DEFINITION OF NATIONAL DRUG CONTROL PRO-
GRAM AGENCY.
Section 1010(6) (21 U.S.C. 1507(6)) is amended to
read as follows:
‘‘(6) the term ‘National Drug Control Program
agency’ means any agency that is responsible for im-
plementing any aspect of the National Drug Control
Strategy, including any agency that receives Federal
funds to implement any aspect of the National Drug
Control Strategy;’’.
SEC. 11. EXTENSION OF DATE FOR TERMINATION OF OF-
FICE OF NATIONAL DRUG CONTROL POLICY.
Section 1009 is amended by striking ‘‘September 30,
1997’’ and inserting ‘‘September 30, 1999’’.
SEC. 12. EXTENSION OF AUTHORIZATION OF APPROPRIA-
TIONS.
Section 1011 is amended by striking ‘‘8 succeeding
fiscal years’’ and inserting ‘‘10 succeeding fiscal years’’.
SEC. 13. REPORT REQUIRED.
Not later than November 1, 1997, the Director of the
Office of National Drug Control Policy shall submit to
Congress a report including—
(1) proposed goals, targets, performance meas-
ures (as described in section 1003(b)(1) of the Na-
tional Narcotics Leadership Act of 1998 (21 U.S.C.
1502(b)(1)), and specific initiatives with respect to
the National Drug Control Program, including the
High Intensity Drug Trafficking Area Program; and
(2) proposals to coordinate the efforts of all
National Drug Control Program agencies.
Æ